1. Home
  2. DSY vs PLUR Comparison

DSY vs PLUR Comparison

Compare DSY & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

HOLD

Current Price

$0.20

Market Cap

28.5M

Sector

N/A

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.62

Market Cap

28.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSY
PLUR
Founded
2020
2001
Country
China
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.5M
28.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DSY
PLUR
Price
$0.20
$3.62
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
148.0K
12.5K
Earning Date
01-01-0001
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
120.37
N/A
EPS
0.01
N/A
Revenue
$7,323,356.00
$1,326,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
$18.75
N/A
Revenue Growth
16.37
121.74
52 Week Low
$0.21
$2.82
52 Week High
$7.33
$7.13

Technical Indicators

Market Signals
Indicator
DSY
PLUR
Relative Strength Index (RSI) 26.95 57.23
Support Level $0.22 $3.30
Resistance Level $0.25 $3.90
Average True Range (ATR) 0.03 0.20
MACD -0.00 0.05
Stochastic Oscillator 8.62 60.87

Price Performance

Historical Comparison
DSY
PLUR

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: